Raleigh Capital Management Inc. Laboratory Corp Of America Holdings Transaction History

Raleigh Capital Management Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$209.01 - $232.56 $2,926 - $3,255	14 Added 9.21%	166 $36,000
Q4 2023 Feb 21, 2024	BUY	$197.69 - $227.29 $4,546 - $5,227	23 Added 17.83%	152 $34,000
Q3 2023 Dec 06, 2023	SELL	$201.05 - $221.7 $24,528 - $27,047	-122 Reduced 48.61%	129 $25,000
Q2 2023 Jul 25, 2023	BUY	$211.93 - $241.33 $7,629 - $8,687	36 Added 16.74%	251 $60,000
Q1 2023 May 22, 2023	BUY	$213.32 - $257.83 $12,799 - $15,469	60 Added 38.71%	215 $49,000
Q4 2022 Feb 07, 2023	SELL	$203.72 - $248.97 $104,712 - $127,970	-514 Reduced 76.83%	155 $36,000
Q3 2022 Nov 09, 2022	BUY	$204.81 - $262.19 $10,445 - $13,371	51 Added 8.25%	669 $137,000
Q2 2022 Aug 30, 2022	BUY	$213.86 - $277.87 $427 - $555	2 Added 0.32%	618 $145,000
Q1 2022 May 12, 2022	SELL	$259.82 - $298.18 $519 - $596	-2 Reduced 0.32%	616 $162,000
Q4 2021 Feb 16, 2022	BUY	$271.6 - $314.21 $167,848 - $194,181	618 New	618 $194,000

105

2.29M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $21.4B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Raleigh Capital Management Inc., based on Form 13F filings with the SEC.

Stay updated on Raleigh Capital Management Inc. with notifications on news.